- Home
- SKLZ vs XGN Comparison
SKLZ vs XGN Comparison
Compare SKLZ & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKLZ
- XGN
- Stock Information
- Founded
- SKLZ 2012
- XGN 2002
- Country
- SKLZ United States
- XGN United States
- Employees
- SKLZ N/A
- XGN N/A
- Industry
- SKLZ EDP Services
- XGN Medical Specialities
- Sector
- SKLZ Technology
- XGN Health Care
- Exchange
- SKLZ Nasdaq
- XGN Nasdaq
- Market Cap
- SKLZ 136.4M
- XGN 138.3M
- IPO Year
- SKLZ N/A
- XGN 2019
- Fundamental
- Price
- SKLZ $8.54
- XGN $10.10
- Analyst Decision
- SKLZ Buy
- XGN Strong Buy
- Analyst Count
- SKLZ 1
- XGN 4
- Target Price
- SKLZ $14.00
- XGN $11.75
- AVG Volume (30 Days)
- SKLZ 105.8K
- XGN 387.3K
- Earning Date
- SKLZ 08-07-2025
- XGN 07-29-2025
- Dividend Yield
- SKLZ N/A
- XGN N/A
- EPS Growth
- SKLZ N/A
- XGN N/A
- EPS
- SKLZ N/A
- XGN N/A
- Revenue
- SKLZ $93,320,000.00
- XGN $58,862,000.00
- Revenue This Year
- SKLZ $17.44
- XGN $19.68
- Revenue Next Year
- SKLZ $12.03
- XGN $13.68
- P/E Ratio
- SKLZ N/A
- XGN N/A
- Revenue Growth
- SKLZ N/A
- XGN 3.89
- 52 Week Low
- SKLZ $3.54
- XGN $2.38
- 52 Week High
- SKLZ $9.11
- XGN $10.34
- Technical
- Relative Strength Index (RSI)
- SKLZ 58.33
- XGN 77.40
- Support Level
- SKLZ $8.10
- XGN $9.39
- Resistance Level
- SKLZ $9.11
- XGN $9.90
- Average True Range (ATR)
- SKLZ 0.50
- XGN 0.44
- MACD
- SKLZ 0.03
- XGN 0.03
- Stochastic Oscillator
- SKLZ 77.29
- XGN 88.52
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.